Intralesional 5-fluorouracil in the treatment of keloids: An open clinical and histopathologic study

Hautmann, 1999, Keloids and hypertrophic scars, 281 Berman, 1998, The treatment of hypertrophic scars and keloids, Eur J Dermatol, 8, 591 Shaffer, 2002, Keloidal scars: a review with a critical look at therapeutic options, J Am Acad Dermatol, 46, S63, 10.1067/mjd.2002.120788 Tsao, 2002, Scar management: keloid, hypertrophic, atrophic and acne scars, Semin Cutan Med Surg, 21, 46, 10.1016/S1085-5629(02)80719-2 Bodokh, 1996, Treatment of keloids with intralesional bleomycin, Ann Dermatol Venereol, 123, 791 Espana, 2001, Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures, Dermatol Surg, 27, 23, 10.1111/j.1524-4725.2001.99315.x Pollack, 1982, The surgical treatment of keloids, J Dermatol Surg Oncol, 8, 1045, 10.1111/j.1524-4725.1982.tb01092.x Fitzpatrick, 1999, Treatment of inflamed hypertrophic scars using intralesional 5-FU, Dermatol Surg, 25, 224, 10.1046/j.1524-4725.1999.08165.x Uppal, 2001, The effects of a single dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision, Plast Reconstr Surg, 108, 1218, 10.1097/00006534-200110000-00018 Gupta, 2002, Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids, Dermatology, 204, 130, 10.1159/000051830 Manusciatti, 2002, Treatment response of keloidal and hypertrophic sternotomy scars, Arch Dermatol, 138, 1149, 10.1001/archderm.138.9.1149 Ghoshal, 1997, An alternative molecular mechanism of action of 5-fluoruracil, a potent anti-cancer drug, Biochem Pharmacol, 53, 1569, 10.1016/S0006-2952(97)00040-3 Blumenkranz, 1984, Selection of the therapeutic agents for intra-ocular proliferative disease: cell culture evaluation, Arch Ophthalmol, 102, 598, 10.1001/archopht.1984.01040030470029 Santucci, 2001, Keloids and hypertrophic scars of Caucasians show morphologic and immunophenotypic profiles, Virchows Arch, 438, 457, 10.1007/s004280000335 From, 1999, Neoplasms, pseudoneoplasms and hyperplasias of the dermis, 1163 Blackburn, 1966, Histologic basis of keloid and hypertrophic scar differentiation: clinicopathologic correlation, Arch Pathol, 82, 65 Tonnesen, 2000, Angiogenesis in wound healing, J Invest Dermatol, 5, 40, 10.1046/j.1087-0024.2000.00014.x Lee, 1999, Expression of transforming growth factor beta 1, 2 and 3 proteins in keloids, Ann Plast Surg, 43, 179, 10.1097/00000637-199943020-00013 Polo, 1999, Effect of TGF-β2 on proliferative fibroblast cell kinetics, Ann Plast Surg, 43, 185, 10.1097/00000637-199902000-00014 Wang, 1999, Exogenous transforming growth factor beta 2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats, J Surg Res, 87, 194, 10.1006/jsre.1999.5757 Younai, 1994, Modulation of collagen synthesis by transforming growth factor beta in keloid and hypertrophic scar fibroblasts, Ann Plast Surg, 33, 148, 10.1097/00000637-199408000-00005 Babu, 1989, Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing, Mol Cell Biol, 9, 1642, 10.1128/MCB.9.4.1642 Peltonen, 1992, Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor beta 1 mRNA, J Invest Dermatol, 99, 650